Products and medicines - Bristol Myers Squibb (original) (raw)

Report side effects or product quality complaints

Report side effects or product quality complaints about legacy celgene products (ABRAXANE®, IDHIFA®, INREBIC®, ISTODAX®, POMALYST®, REBLOZYL®, REVLIMID®, THALOMID®, VIDAZA®)

Below is a list of our company's marketed products. Any linked documents and websites are intended only for U.S. residents 18 years or older, as the availability of medicines and the indications for which they are approved can vary with country and region.

ABECMA® (idecabtagene vicleucel)

ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound)

AZACTAM® (aztreonam for injection, USP)

BREYANZI® (lisocabtagene maraleucel)

COBENFYTM (xanomeline and trospium chloride)

EVOTAZ® (atazanavir and cobicistat)

KENALOG®-10 (triamcinolone acetonide)

KENALOG® -40 (triamcinolone acetonide) and
KENALOG® -80 (triamcinolone acetonide)

ONUREG® (azacitidine tablets)

OPDIVO QVANTIGTM (nivolumab and hyaluronidase-nvhy)

OPDUALAG™ (nivolumab and relatlimab-rmbw)

REBLOZYL® (luspatercept-aamt)

SOTYKTU™ (deucravacitinib)

Please click below to see the full U.S. Prescribing Information, including Boxed WARNING and Medication Guide/Patient Informationfor: